Risk factor
Strong trading liquidity
Profitability factor
Very low or no dividends
About
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of ILMN is 123 and suggests 5% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decre
Buy
Sell